“Subcutaneous Administration of Tocilizumab Is Effective in Myointimal Hyperplasia Remodelling in Refractory Takayasu Arteritis”. 2017. Reumatismo 69 (4): 184-88. https://doi.org/10.4081/reumatismo.2017.1013.